GC Biopharma Market Cap

GC Biopharma has a market cap or net worth of 1.52 trillion as of February 21, 2025. Its market cap has increased by 19.98% in one year.

Market Cap

1.52T

Enterprise Value

2.60T

Revenue

1.64T

Ranking

n/a

PE Ratio

n/a

Stock Price

131,400.00

Market Cap Chart

Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.52T, an increase of 5,130.66%. That is a compound annual growth rate of 14.35%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	1,521.38B	-25.74%
Dec 30, 2024	2,048.67B	43.03%
Dec 28, 2023	1,432.35B	-3.09%
Dec 29, 2022	1,478.01B	-40.60%
Dec 30, 2021	2,488.07B	-46.31%
Dec 30, 2020	4,633.75B	206.42%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	81.78T
Celltrion	38.27T
Yuhan	9,148.44B
SK Biopharmaceuticals	9,053.01B
SK bioscience	3,756.75B
Hanmi Pharm.	3,436.34B
Hanmi Science	1,963.70B
Hanall Biopharma	1,934.60B

Market Cap Rankings